Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Reprogenetics

Reprogenetics
2001 FOUNDED
M&A STATUS
61-70 EMPLOYEES
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Operator of genetics laboratory. The company provides laboratory services like preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD) used during the in-vitro fertilization (IVF) process.

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Laboratory Services (Healthcare)
Acquirer
CooperSurgical
Primary Office
  • 3 Regent Street
  • Suite 301
  • Livingston, NJ 07039
  • United States

Reprogenetics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Reprogenetics‘s full profile, request access.

Request full access to PitchBook

Reprogenetics Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
00000000 Private Equity-Backed Paterna, Spain 000 000000000000
To view this company’s complete list of competitors, request access »

Reprogenetics Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Reprogenetics‘s full profile, request access.

Request full access to PitchBook

Reprogenetics Executive Team (1)

Name Title Board
Seat
Contact
Info
Santiago Munne Ph.D Founder, President & Director